Appointments: Novartis And GSK Fill Key R&D Roles, Celgene Board Changes And Others
Executive Summary
This week's announcements include Novartis's replacement for Vas Narasimhan as head of global development, GlaxoSmithKline's new head of worldwide business development for pharmaceuticals research & development, new board members at Celgene, an interim CEO at Nordic Nanovector, and changes at Vectura, PureTech Health and Exicure.
You may also be interested in...
Pipeline Watch: 22 Approvals And 15 Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: New Roles Filled at Lisata Therapeutics, Roquefort Therapeutics and Voyager Therapeutics
This week's executive changes in the industry include new CEOs at Roquefort Therapeutics, Lisata Therapeutics and Everest Medicines, while Vyriad and RenovoRx get new chief operating officers.
Publisher's Spotlight: Scrip Awards Announces 2022 Finalists
We are delighted to announce the shortlist for the 18th Annual Scrip Awards.